(Q52906615)

English

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.

scientific article published on 17 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

0 references

1 reference

based on heuristic

inferred from title

author name string

V Conter

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

M Aricò

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

G Basso

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

A Biondi

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

E Barisone

5

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

C Messina

6

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

R Parasole

7

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

G De Rossi

8

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

F Locatelli

9

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

A Pession

10

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

N Santoro

11

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

C Micalizzi

12

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

M Citterio

13

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

C Rizzari

14

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

D Silvestri

15

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

R Rondelli

16

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

L Lo Nigro

17

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

O Ziino

18

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

A M Testi

19

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

G Masera

20

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

M G Valsecchi

21

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

Associazione Italiana di Ematologia ed Oncologia Pediatrica

22

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

publication date

17 December 2009

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

24

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

255-264

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

https://scigraph.springernature.com/pub.10.1038/leu.2009.250

0 references

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

21 January 2018

Treating childhood acute lymphoblastic leukaemia (ALL): Summary of ten years' experience in Italy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Ita

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.250

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.250

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/20016536

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52906615&oldid=1456801097"